International Journal of Research and Reports in Hematology

  • About
    • About the Journal
    • Submissions & Author Guideline
    • Accepted Papers
    • Editorial Policy
    • Editorial Board Members
    • Reviewers
    • Printed Hard copy
    • Subscription
    • Membership
    • Publication Ethics and Malpractice Statement
    • Digital Archiving
    • Contact
  • Archives
  • Indexing
  • Publication Charge
  • Submission
  • Testimonials
  • Announcements
Advanced Search
  1. Home
  2. Archives
  3. 2022 - Volume 5 [Issue 2]
  4. Case Study

Submit Manuscript


Subscription



  • Home Page
  • Author Guidelines
  • Editorial Board Member
  • Editorial Policy
  • Propose a Special Issue
  • Membership

The Prophylactic Treatment of COVID-19 in a Renal Failure and Hodgkin Lymphoma Patient with Convalescent Plasma

  • Soykan Biçim
  • İlhami Berber
  • Mehmet Ali Erkurt
  • İrfan Kuku
  • Emin Kaya
  • Yılmaz Bilgiç
  • Ahmet Sarıcı
  • Ahmet Kaya
  • Emine Hidayet
  • Ayşe Uysal

International Journal of Research and Reports in Hematology, Page 1-5

Published: 20 January 2022

  • View Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract


COVID-19 is a viral infectious disease that is thought to have emerged from an animal market in Wuhan, People's Republic of China, in December 2019, and subsequently caused a pandemic. Despite the fact that one year has passed since the onset of the epidemic and many treatment agents have been tried, there is still no approved treatment. Convalescent plasma therapy is a passive immunization method and holds promise in the treatment of COVID-19. In this study, we observed that asymptomatic COVID-19 infection was effectively treated with convalescent plasma in a young patient with a diagnosis of Hodgkin lymphoma, acute renal failure also who received R-DHAP (Rituximab – Cisplatin – Cytarabine - Dexamethasone) chemotherapy treatment. We think that this treatment may be more effective when it is administered in an earlier stage of disease in asymptomatic patients.


Keywords:
  • COVID-19
  • convalescent plasma
  • hodgkin lymphoma
  • Full Article – PDF
  • Review History

How to Cite

Biçim, S., Berber, İlhami, Ali Erkurt, M., Kuku, İrfan, Kaya, E., Bilgiç, Y., Sarıcı, A., Kaya, A., Hidayet, E., & Uysal, A. (2022). The Prophylactic Treatment of COVID-19 in a Renal Failure and Hodgkin Lymphoma Patient with Convalescent Plasma. International Journal of Research and Reports in Hematology, 5(2), 1-5. Retrieved from https://journalijr2h.com/index.php/IJR2H/article/view/66
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Abstract View: 105 times
    PDF Download: 28 times

Download Statistics

  • Linkedin
  • Twitter
  • Facebook
  • WhatsApp
  • Telegram
Make a Submission / Login
Information
  • For Readers
  • For Authors
  • For Librarians
Current Issue
  • Atom logo
  • RSS2 logo
  • RSS1 logo


© Copyright 2010-Till Date, International Journal of Research and Reports in Hematology. All rights reserved.